CN1089862A - Anti-inflammatory tablet for treatment of arthritis - Google Patents
Anti-inflammatory tablet for treatment of arthritis Download PDFInfo
- Publication number
- CN1089862A CN1089862A CN 93115867 CN93115867A CN1089862A CN 1089862 A CN1089862 A CN 1089862A CN 93115867 CN93115867 CN 93115867 CN 93115867 A CN93115867 A CN 93115867A CN 1089862 A CN1089862 A CN 1089862A
- Authority
- CN
- China
- Prior art keywords
- radix
- aspirin
- semen strychni
- rhizoma
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A kind of anti-inflammatory tablet for treatment of arthritis adopts prescription and weight (part) ratio to be: Semen Strychni 19-21, Herba Ephedrae 19-21, aspirin 7.5-8.5, sucrose 11-19.And can choose 16 kinds of components such as adding Radix Ginseng Rubra, Cornu Cervi Pantotrichum, Radix Achyranthis Bidentatae, Radix Saposhnikoviae, Cortex Illici difengpi.Advantage of the present invention is: based on Chinese medicines such as Semen Strychni, Herba Ephedraes, be auxilliary with Western medicine aspirin, the Chinese medicine and western medicine combination not only effects a permanent cure but also take stopgap measures, and both complement each other, and diseases such as lumbago and skelalgia, arthroncus, rheumatoid are had significant curative effect; The clinical verification obvious effective rate is 66.7%, and effective percentage is 33.3%; Compare with similar drug, dosage is little, and convenient drug administration has reduced the trouble of taking medicine the patient being brought.
Description
The invention belongs to a kind of medicine of treatment of arthritis.
Rheumatic and rheumatoid arthritis are commonly encountered diseases, frequently-occurring disease, bring very big misery to the patient, serious energy disability.The medicine of treatment rheumatism and rheumatoid arthritis has Western medicine and Chinese medicine two classes at present; Western medicine has certain alleviation and curative effect to disease, but anosis therapeutical effect because of property can not effect a radical cure, the development that can not ward off disease and the generation of complication, and have certain side effect, as producing the reaction of harmonization of the stomach intestinal, and blood coagulation disorders, anaphylaxis etc.Chinese medicine is controlled rheumatic and dialectical the executing of rheumatoid arthritis, and permanent curing action is preferably arranged, few side effects, but taking dose is big, and administration time is long, and flavour of a drug are difficult for accepting, and the patient is difficult to adhere to.
The purpose of this invention is to provide a kind of anti-inflammatory tablet for treatment of arthritis, the Chinese medicine and western medicine combination not only takes stopgap measures but also effect a permanent cure, and to diseases such as lumbago and skelalgia, arthroncus, rheumatoids, curative effect height, toxic and side effects are little.Taking dose is few, convenient drug administration.
The object of the present invention is achieved like this:
Prescription and weight (part) ratio are as follows:
Semen Strychni 19-21 Herba Ephedrae 19-21
Aspirin 7.5-8.5 sucrose 11-19
Preparation method: with the Herba Ephedrae water boiling and extraction, with extracting liquid filtering, be condensed into thick extractum, drying; Powdered extract and Semen Strychni are merged pulverizing, with aspirin and above-mentioned fine powder mix homogeneously, add syrup granulation, drying, beat the sheet packing.
Above-mentioned prescription of the present invention can be chosen and add following at least a component: Radix Ginseng Rubra, Cornu Cervi Pantotrichum, Os pardi, Radix Achyranthis Bidentatae, Radix Saposhnikoviae, Cortex Illici difengpi, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, Rhizoma Homalomenae, Myrrha (processed), Olibanum (system), Radix Glycyrrhizae, charred Cortex Eucommiae, MUZHUA, Ramulus Cinnamomi, calcium hydrogen phosphate.
The ratio of aforementioned component (weight portion) is constant, and the ratio (weight portion) of choosing component is as follows:
Radix Ginseng Rubra 0.7-0.8 Cornu Cervi Pantotrichum 0.7-0.8
Os pardi 0.7-0.8 Radix Achyranthis Bidentatae 1.4-1.6
Radix Saposhnikoviae 1.4-1.6 Cortex Illici difengpi 1.4-1.6
Rhizoma Et Radix Notopterygii 1.4-1.6 Radix Angelicae Pubescentis 1.4-1.6
Rhizoma Homalomenae 1.4-1.6 Myrrha (processed) 1.4-1.6
Olibanum (system) 1.4-1.6 Radix Glycyrrhizae 1.4-1.6
Charred Cortex Eucommiae 1.4-1.6 Fructus Chaenomelis 1.4-1.6
Ramulus Cinnamomi 1.4-1.6 calcium hydrogen phosphate 2.5-3.5
With the Radix Saposhnikoviae chosen, Cortex Illici difengpi, Rhizoma Et Radix Notopterygii, Ramulus Cinnamomi wherein one or more add water distillation and extraction volatile oil, the medicinal residues and the aforesaid Herba Ephedrae of one or more and said extracted volatile oil of the Rhizoma Homalomenae chosen, Radix Achyranthis Bidentatae, MUZHUA, charred Cortex Eucommiae, Radix Glycyrrhizae, Radix Angelicae Pubescentis are merged water boiling and extraction, extracting solution is condensed into thick extractum, drying; One or more and aforesaid Semen Strychni, above-mentioned powdered extract of the Radix Ginseng Rubra chosen, Cornu Cervi Pantotrichum, Os pardi merged pulverize, at last with calcium hydrogen phosphate, aspirin and above-mentioned fine powder mixing, add syrup and granulate, dry, beat sheet, evenly mix volatile oil, coating.
Advantage of the present invention is: (1) is based on Chinese medicines such as Semen Strychni, Herba Ephedraes, with Western medicine aspirin is auxilliary, the Chinese medicine and western medicine combination, Chinese medicine effects a permanent cure, Western medicine takes stopgap measures, both complement each other, and diseases such as the lumbago and skelalgia that causes because of deficiency of both QI and blood and wind, cold, wet heresy, arthroncus, rheumatoid are had significant curative effect; (2) because Western medicine aspirin plays synergism to Chinese medicine, not only improve the curative effect of medicine, and reduced the toxic and side effects of medicine, help rehabilitation of patients, through preliminary clinical experiment, obvious effective rate is 66.7%, and effective percentage is 33.3%; (3) compare with similar drug, dosage is little, and convenient drug administration has reduced the trouble of taking medicine the patient being brought.
Provide embodiments of the invention below.
Embodiment 1
Prescription and weight (part) ratio:
Semen Strychni 20 Herba Ephedraes 20
Aspirin 7.5 sucrose 15
Preparation method: with the Herba Ephedrae water boiling and extraction, at twice, each 2 hours, merge extractive liquid,, filtration were condensed into thick extractum, drying; Powdered extract and Semen Strychni merging are ground into fine powder; With aspirin and above-mentioned fine powder mix homogeneously, add concentration and be 50% syrup and granulate, dry, beat sheet, packing.
Embodiment 2
Prescription and weight (part) ratio:
Semen Strychni 19 Herba Ephedraes 19
Aspirin 8 sucrose 15
Preparation method is the same.
Embodiment 3
Semen Strychni 21 Herba Ephedraes 21
Aspirin 8.5 Radix Ginseng Rubra 0.7
Cornu Cervi Pantotrichum 0.7 Os pardi 0.7
Radix Achyranthis Bidentatae 1.4 calcium hydrogen phosphate 2.8
Sucrose 16
Preparation method: with Herba Ephedrae, Radix Achyranthis Bidentatae water boiling and extraction, at twice, 1.5 hours each time, 2 hours for the second time, merge extractive liquid, filtered, and is condensed into thick extractum, drying; Powdered extract and Semen Strychni, Radix Ginseng Rubra, Os pardi merging are ground into fine powder; With calcium hydrogen phosphate, aspirin and fine powder mix homogeneously, the syrup that adds concentration 50% granulates, dry, knit sheet, coating.
Embodiment 4
Prescription and weight (part) ratio are as follows:
Semen Strychni 21 Herba Ephedraes 21
Aspirin 8.5 Radix Ginseng Rubra 0.75
Cornu Cervi Pantotrichum 0.75 Os pardi 0.75
Radix Achyranthis Bidentatae 1.5 Radix Saposhnikoviaes 1.45
Cortex Illici difengpi 1.4 Rhizoma Et Radix Notopterygiis 1.4
Radix Angelicae Pubescentis 1.4 Rhizoma Homalomenae 1.4
Myrrha (processed) 1.4 Olibanums (system) 1.4
Radix Glycyrrhizae 1.4 charred Cortex Eucommiaes 1.4
Fructus Chaenomelis 1.4 Ramulus Cinnamomi 1.4
Calcium hydrogen phosphate 2.7 sucrose 16
Preparation method: Radix Saposhnikoviae, Cortex Illici difengpi, Rhizoma Et Radix Notopterygii, Ramulus Cinnamomi are added water distillation and extraction volatile oil; Water boiling and extraction is carried out in the medicinal residues merging of Rhizoma Homalomenae, Radix Achyranthis Bidentatae, Fructus Chaenomelis, charred Cortex Eucommiae, Radix Glycyrrhizae, Radix Angelicae Pubescentis, Herba Ephedrae and said extracted volatile oil, extracting solution is condensed into thick extractum, drying; Radix Ginseng Rubra, Cornu Cervi Pantotrichum, Os pardi, Semen Strychni and exsiccant extractum merged be ground into fine powder, at last with calcium hydrogen phosphate, aspirin and fine powder mixing, the syrup that adds 50% concentration is granulated, and is dry, beat sheet, mix volatile oil and mix thoroughly, coating.
Embodiment 5
Prescription and weight (part) ratio are as follows:
Semen Strychni 21 Herba Ephedraes 21
Aspirin 8 Radix Ginseng Rubra 0.8
Cornu Cervi Pantotrichum 0.8 Cortex Illici difengpi 1.6
Radix Angelicae Pubescentis 1.6 Myrrhas 1.6
Radix Glycyrrhizae 1.5 Olibanums 1.5
Charred Cortex Eucommiae 1.5 Rhizoma Et Radix Notopterygiis 1.5
Aspirin 8.5 calcium hydrogen phosphate 2.0
Sucrose 16
Preparation method is the same.
Claims (2)
1, a kind of anti-inflammatory tablet for treatment of arthritis is characterized in that prescription and part by weight (part) are:
Semen Strychni 19-21 Herba Ephedrae 19-21
Aspirin 7.5-8.5 sucrose 11-19.
2, anti-inflammatory tablet for treatment of arthritis according to claim 1 is characterized in that: prescription can be chosen and add following at least a component: Radix Ginseng Rubra, Cornu Cervi Pantotrichum, Os pardi, Radix Achyranthis Bidentatae, Radix Saposhnikoviae, Cortex Illici difengpi, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, Rhizoma Homalomenae, Myrrha (processed), Olibanum (system), Radix Glycyrrhizae, charred Cortex Eucommiae, Fructus Chaenomelis, Ramulus Cinnamomi, calcium hydrogen phosphate;
The ratio of aforementioned component (weight portion) is constant, and the ratio (weight portion) of choosing component is as follows:
Radix Ginseng Rubra 0.7-0.8 Cornu Cervi Pantotrichum 0.7-0.8
Os pardi 0.7-0.8 Radix Achyranthis Bidentatae 1.4-1.6
Radix Saposhnikoviae 1.4-1.6 Cortex Illici difengpi 1.4-1.6
Rhizoma Et Radix Notopterygii 1.4-1.6 Radix Angelicae Pubescentis 1.4-1.6
Rhizoma Homalomenae 1.4-1.6 Myrrha (processed) 1.4-1.6
Olibanum (system) 1.4-1.6 Radix Glycyrrhizae 1.4-1.6
Charred Cortex Eucommiae 1.4-1.6 Fructus Chaenomelis 1.4-1.6
Ramulus Cinnamomi 1.4-1.6 calcium hydrogen phosphate 2.5-3.5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93115867 CN1089862A (en) | 1993-10-22 | 1993-10-22 | Anti-inflammatory tablet for treatment of arthritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93115867 CN1089862A (en) | 1993-10-22 | 1993-10-22 | Anti-inflammatory tablet for treatment of arthritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1089862A true CN1089862A (en) | 1994-07-27 |
Family
ID=4991399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 93115867 Pending CN1089862A (en) | 1993-10-22 | 1993-10-22 | Anti-inflammatory tablet for treatment of arthritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1089862A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1295601A4 (en) * | 2000-04-05 | 2007-12-12 | Veniamin Abramovich Khazanov | Pharmaceutical composition based on a non-steroid anti-inflammatory agent |
| JP2011168615A (en) * | 2003-10-16 | 2011-09-01 | Daiichi Sankyo Healthcare Co Ltd | Oral composition containing salicylic acids |
-
1993
- 1993-10-22 CN CN 93115867 patent/CN1089862A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1295601A4 (en) * | 2000-04-05 | 2007-12-12 | Veniamin Abramovich Khazanov | Pharmaceutical composition based on a non-steroid anti-inflammatory agent |
| JP2011168615A (en) * | 2003-10-16 | 2011-09-01 | Daiichi Sankyo Healthcare Co Ltd | Oral composition containing salicylic acids |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1186043C (en) | Exterior-applied medicine for treating osteopathy | |
| CN101632737B (en) | Medicament for relieving pain of human body and preparation method thereof | |
| CN1193775C (en) | Rheumatoid disease treating capsule | |
| CN1966003A (en) | Externally applied medicament for treating rheumatism | |
| CN101085223A (en) | Medicine for treating rheumatism and rheumatoid disease | |
| CN1095674C (en) | Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease | |
| CN1876074A (en) | A constipation-treating medicament and preparation method thereof | |
| CN1053375C (en) | Chinese medicine preparation for hepatosis | |
| CN1129130A (en) | Medicament for treatment of cervical spondylopathy | |
| CN1054773C (en) | Chinese patent drug "Bizhengning" for treatment of arthralgia-syndrome | |
| CN1089862A (en) | Anti-inflammatory tablet for treatment of arthritis | |
| CN1490017A (en) | Medicines against rheunatoid and rheumatic diseases | |
| CN1256130C (en) | Preparation of Chinese traditional medicine for curing skin disease | |
| CN1907353A (en) | Chinese traditional medicine preparation for treating chronic gastritis | |
| CN1255150C (en) | Chinese medicine preparation for curing hyperosteogeny and its preparation method | |
| CN1047524C (en) | Chinese patent medicine, "Naozhenning" for treatment of brain trauma syndrome | |
| CN101036696A (en) | Medicine combination for curing orthopaedics disease and the method for preparing the same | |
| CN1113800A (en) | Chinese drug effecting a radical cure of various gastrosis | |
| CN1051468C (en) | Capsule for curing rheumatism | |
| CN1066047C (en) | Traditional Chinese medicine preparation for treatment of sharp-pointed condyloma | |
| CN1663577A (en) | Chinese medicinal composition for treating rheumatic and rheumatoid arthritis | |
| CN1965968A (en) | Orally administered medicinal powder for treating gastric diseases | |
| CN1081042C (en) | Traditional Chinese medicinal composition for stopping drug taking and preparation process thereof | |
| CN1799614A (en) | Chinese traditional medicine composition for treating liver and kidney diseases and preparation method thereof | |
| CN1470271A (en) | Chinese medicinal compound preparation for treating liver fibrillation disease and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |